NEW HAVEN, Conn. (AP) _ Bioasis Technologies Inc. (BIOAF) on Thursday reported a loss of $732,000 in its fiscal third quarter.

The New Haven, Connecticut-based company said it had a loss of 1 cent per share.

The biotech drug developer posted revenue of $110,600 in the period. Its adjusted revenue was $111,000.

In the final minutes of trading on Thursday, the company's shares hit 3 cents. A year ago, they were trading at 24 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIOAF at https://www.zacks.com/ap/BIOAF

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News